"The FDA added it will prioritize applications from companies that demonstrate safety and nutritional standards and can expedite large quantities of their products to U.S. shelves. Senior Biden administration officials, in a call with reporters, said imported formula will come from countries with similar regulatory standards, such as Ireland, the U.K., Australia and New Zealand."
GLAH
A2M Price at posting:
$4.15 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
More excerpt from CNBC for convenient viewing...
(20min delay)